Interleukin-6 (IL-6) is a multifunctional cytokine that normally modulates a variety of physiological events including cell survival and apoptosis [1], but its dis-regulation has been implicated in various diseases including cancer [2-4] for which it has been associated with tumor progression, drug resistance and poor prognosis [5-7]. The gene discussed is IL6; the disease is neoplasm.